Posted in M&A / Deals Eli Lilly outlays $7.8bn to acquire sleep drug biotech Centessa April 1, 2026 Pharmaceutical Technology Whether the deal reaches its full value hinges on US regulatory milestones for Centessa’s lead candidate, cleminorexton. M&A / DealsNeuroscienceRead full story